BrainStorm Cell Therapeutics
BCLI
#9833
Rank
C$1.66 M
Marketcap
$0.31
Share price
3.51%
Change (1 day)
14.92%
Change (1 year)

EPS for BrainStorm Cell Therapeutics (BCLI)

EPS in 2023 (TTM): -$0.80

According to BrainStorm Cell Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.80. In 2022 the company made an earnings per share (EPS) of -$0.90 an increase over its 2021 EPS that were of -$0.92.

EPS history for BrainStorm Cell Therapeutics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.80-10.68%
2022-$0.90-2.94%
2021-$0.92-37.04%
2020-$1.461.89%
2019-$1.4451.43%
2018-$0.95159.26%
2017-$0.37-3.57%
2016-$0.38-37.78%
2015-$0.61-33.82%
2014-$0.9236%
2013-$0.6811.11%
2012-$0.6150%
2011-$0.41-50%
2010-$0.81-233.33%
2009$0.61-142.86%
2008-$1.42-65%
2007-$4.07
2005$1.34-108.03%
2004-$16.7313203.07%
2003-$0.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$5.95-844.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$7.72 864.41%๐Ÿ‡บ๐Ÿ‡ธ USA
-$5.44 579.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$25.04-3,228.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.15 44.07%๐Ÿ‡บ๐Ÿ‡ธ USA